Study on SuPerSense Proprioceptive Rehabilitation in Parkinson's Disease
A randomized controlled trial is evaluating the feasibility and efficacy of the SuPerSense device for proprioceptive rehabilitation in Parkinson's disease.
Phase III
Parkinson's Disease rehabilitation market
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing trial of the SuPerSense device represents a potential shift in rehabilitation practices for Parkinson's disease, focusing on proprioceptive feedback. Successful outcomes could enhance patient care and establish SuPerSense as a competitive tool in the neurology market.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor the trial's outcome measures and results, particularly the comparison of SuPerSense-derived metrics with traditional clinical assessments.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.